Altogether, these results suggest that the upregulated CPT1 lipid metabolism plays a critical role in the pathogenesis of the SOD1 G93A familiar form of ALS and that downregulation of CPT1 might be a potential target to restore the hyperactive metabolism. The gene discussed is CPT1A; the disease is amyotrophic lateral sclerosis.